Over the years CVBF has established partnerships at national and international level with hospital centres, universities, companies, research and patients associations as well as public institutes and Ministries.

Moreover, CVBF is Partner in many research networks at national and European level, aimed to promote the interaction and the active involvement of the main stakeholders facilitating the transfer of the achieved know-how at different levels, leading to a strengthening of the scientific excellence promoting national and international research.

Research networks conceived within CVBF are the TEDDY Network, which was developed under the Sixth Framework Programme for Research and Technological Development with the goal of supporting and strengthening the scientific and technological excellence in the paediatric sector in Europe and the Inter-regional Network for Thalassemia. At the end of the funding period, the Task-force was further renewed and now TEDDY is an independent multidisciplinary and multinational Network, where researchers, scientists and health experts are still working together to identify the most appropriate common rules that reflect the specificity of this patient population.

CVBF is partner in EUCROF (European CRO Federation), a non-profit organization founded in 2005 with the aim to promote Clinical Research by improving the knowledge, competences, expertise and skills of Contract Research Organisations (CROs) in Europe. CVBF and its Albanian branch actively participate in the EUCROF activities and in particular in the following Working Groups: Communication, Events and Training, Outsourcing, Paediatric, Patients.

INCiPiT is a network coordinated by Ospedale Pediatrico Bambino Gesù IRCCS and composed by the main Italian Paediatric Hospitals and Scientific Institutes for Research, Hospitalization and Health Care (IRCCS) and other Research Organizations like CVBF, with the aim to promote and support the conduction of all types of clinical trials in the paediatric population by all kinds of sponsor (academic investigators, pharmaceutical industries, contract research organisations).

CVBF is member also of AICRO – Associazione Italiana Contract Research Organisation, founded in 2004 with the aim to ensure quality standards in the practice of clinical trials, promoting the use of GCP (Good Clinical Practice) and relevant regulations (GLP, GMP, etc.), as well as national and international guidelines, where applicable. AICRO collaborates with other authorities and recognized associations in order to further develop clinical research, particularly taking into account the benefit for the patients.

CVBF is part of H-BIO – The Regional High Technology District “Health and Biotechnology”, a high technology cluster, established as a Public/Private Consortium in September 2012 within the Framework Agreement between the Italian Ministry of Education, University and Research (MIUR) and the Apulian Regional Government. H-BIO aims to develop the regional cluster in the strategic sector of Health and Biotechnology, by bringing together the critical mass of scientific expertise and industries operating in the region.




collaborazioni en

1 Abiogen Pharma SpA, Italy
2 Academisch Medisch Centrum bij de Universiteit van Amsterdam, The Netherlands
3 Agenzia Italiana del Farmaco (AIFA), Italy
4 Agenzia per i Servizi Sanitari Regionali, Italy
5 Alfa Wassermann SpA, Italy
6 ApoPharma, Canada
7 Apotex Inc., Canada
8 Aristotle University, Greece
9 ASL di Caserta, Italy
10 Assistance Publique – Hopitaux Paris, France
11 Assobiotec, Italy
12 Associação de Saúde Infantil de Coimbra, Portugal (Coimbra Children’s Hospital)
13 Associazione Microcitemici Campania, Italy
14 AstraZeneca SpA, Italy
15 AUSL n. 4, Matera, Italy
16 Azienda Ospedaliera Cardarelli, Italy
17 Azienda Ospedaliera Cervello, Palermo, Italy
18 Azienda Ospedaliera di Padova, Italy
19 Azienda Ospedaliera Ospedali Riuniti “Villa Sofia-Cervello”, Italy
20 Azienda Ospedaliera Universitaria Arcispedale, S. Anna, Ferrara, Italy
21 Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari, Italy
22 Bayer SpA, Italy
23 Biosearch Italia SpA, Italy
24 Bracco SpA, Italy
25 Brighton Collaboration Foundation, Switzerland
26 Cairo University, Egypt
27 Centre National de Greffe de Moelle Osseuse, Tunis
28 Charité – Universitätsmedizin Berlin, Germany
29 Chiesi Farmaceutici SpA, Italy
30 Consorzio Italiano per la Ricerca in Medicina (CIRM), Italy
31 Confederacion Internacional de Organizaciones de Padres di Ninos con Cancer Asociacion (ICCCPO), The Netherlands
32 Consiglio Nazionale delle Ricerche – Istituto di Tecnologie Biomediche, Italy
33 Consiglio Superiore Sanità, Italy
34 Cypriot Ministry of Health, Cyprus
35 Dompé S.p.A., Italy
36 EG Spa Laboratori Eurogenerici, Italy
37 Erasmus Universitair Medisch Centrum Rotterdam (EMC), The Netherlands
38 ESPID Foundation, Germany
39 European Medicines Agency (EMA), UK
40 Farmindustria, Italy
41 Federfarma, Italy
42 Fondazione Italiana Leonardo Giambrone per la guarigione dalla Thalassemia, Italy
43 Fondazione Penta Onlus, Italy
44 Fondazione per la Ricerca Farmacologica Gianni Benzi Onlus, Italy
45 Fundación para la Cooperación y Salud Internacional Carlos III, CISATER Centre, Spain
46 Fundacion Vasca de Innovacion e Investigacion Sanitarias, Spain
47 Geniko Nosokomeio Paidon Athinon I Agia Sophia – Paidon Pentelis (AGIA SOPHIA), Greece
48 Gentium SpA, Italy
49 Gruppo Italiano per gli Studi di Farmacoeconomia (GISF), Italy
50 Helsingin ja Uudenmaan Sairaanhoitopiirin Kuntayhtymä, Finland
51 I.RI.D.I.A. SrL, Italy
52 Indena, Italy
53 Institut National de la Sante et de la Recherche Medicale, France
54 Institute of Physiology, Academy of Sciences, Lab. of Neurophysiology of Memory, Czech Republic
55 Instytut Pomnik Centrum Zdrowia Dziecka, Poland
56 Istituto di Fisiologia Clinica, CNR, Pisa, Italy
57 Istituto Giannina Gaslini, Italy
58 Istituto Scientifico Biomedico Euro Mediterraneo, Brindisi, Italy
59 Istituto Superiore Sanità (ISS), Italy
60 Italfarmaco, Italy
61 Janssen-Cilag SpA, Italy
62 Karolinska Institutet, Department of  Woman and Child Health, Sweden
63 Kedrion SpA, Italy
64 Korpo, Italy
65 Linköpings Universitet, Sweden
66 Medical Research Council – Clinical Trials Unit, UK
67 Mediterranea, Italy
68 Ministero del Bilancio, Italy
69 Ministero del Tesoro, Italy
70 Ministero dell’Ambiente, Italy
71 Ministero della Programmazione Economica, Italy
72 Ministero della Salute, Italy
73 Ministero delle Pari Opportunità, Italy
74 National and Kapodistrian University of Athens, Greece
75 National Center for Child Health and Development, Japan
76 NICOX, France
77 Novartis Farma SpA, Italy
78 Novuspharma, Italy
79 Ospedale Pediatrico Bambino Gesù, Italy
80 Pedianet, Italy
81 Pharmaceutical Research Management Srl (PHARM), Italy
82 Pierre Fabre Pharma SrL, Italy
83 Policlinico Universitario, Palermo, Italy
84 Promefarm, Italy
85 Qender Spitalore Universitare Nenea Tirane, Albania
86 Radboud University Nijmegen Medical Centre, The Netherlands
87 Regione Basilicata, Italy
88 Regione Lombardia, Italy
89 Regione Piemonte, Italy
90 Regione Puglia, Italy
91 Roche SpA, Italy
92 Romanian Angel Appeal, Romania
93 Serono Ind. Farmaceutica SpA, Italy
94 Servicio Madrileño de Salud, Spain
95 Sigma-Tau Ind. Farm. Riunite  SpA, Italy
96 Sihtasutus Tartu Uelikooli Kliinikum, Estonia
97 Società Italiana Attività Regolatorie (SIAR), Italy
98 Società Italiana di Farmacologia (SIF), Italy
99 Società Italiana di Pediatria (SIP), Italy
100 Softeco Sismat S.p.A., Italy
101 St George’s Hospital Medical School, UK
102 Synapse Research Management Partners SL, Spain
103 Technion – Israel Institute of Technology, Israel
104 Tecnofarmaci – Società Consortile per Azioni – per lo Sviluppo della Ricerca Farmaceutica, Italy
105 The European Society for Paediatric Infectious Diseases (ESPID), The Netherlands
106 The Hospital for Sick Children, Canada
107 The School of Pharmacy, University Of London, UK
108 The University of Edinburg, UK
109 The University of Liverpool, UK
110 Therakind Ltd, UK
111 United States Department of Health and Human Services, USA
112 Universidad de Barcelona, Spain
113 Università Cattolica del Sacro Cuore, Italy
114 Università degli Studi di Bari, Italy
115 Università degli Studi di Bologna, Italy
116 Università degli Studi di Chieti, Italy
117 Università degli Studi di Firenze, Italy
118 Università degli Studi di Milano, Italy
119 Università degli Studi di Napoli, Italy
120 Università degli Studi di Pavia, Italy
121 Università degli Studi di Torino, Italy
122 Universitätsklinikum Erlangen (UKER), Germany
123 Universite de Liege, Belgium
124 Universiteit Antwerpen, Belgium
125 Universiteit Leiden, The Netherlands
126 University College London, UK
127 University Hospital Center “Mother Teresa” – National hemoglobinopathies Center, Albania
128 University Hospital La Paz. Fundación para la Investigación Biomédica, Spain
129 University Medical Center Freiburg, Germany
130 University Medical Centre Ljubljana, Slovenia
131 University of Tartu, Estonia
132 Valeas, Italy
133 Vereniging Samenwerkende Ouder- En Patientenorganisaties, The Netherlands
134 Vilnius University Children Hospital, Lithuania
135 World Health Organization, Switzerland